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Abstract
Despite being the agent of life-threatening meningitis, Neisseria meningitidis is usually carried asymptomatically in the
nasopharynx of humans and only occasionally causes disease. The genetic bases for virulence have not been entirely
elucidated and the search for new virulence factors in this species is hampered by the lack of an animal model
representative of the human disease. As an alternative strategy we employ a molecular epidemiological approach to
establish a statistical association of a candidate virulence gene with disease in the human population. We examine the
distribution of a previously-identified genetic element, a temperate bacteriophage, in 1288 meningococci isolated from
cases of disease and asymptomatic carriage. The phage was over-represented in disease isolates from young adults
indicating that it may contribute to invasive disease in this age group. Further statistical analysis indicated that between
20% and 45% of the pathogenic potential of the five most common disease-causing meningococcal groups was linked to
the presence of the phage. In the absence of an animal model of human disease, this molecular epidemiological approach
permitted the estimation of the influence of the candidate virulence factor. Such an approach is particularly valuable in the
investigation of exclusively human diseases.
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Introduction
Despite its notoriety as the causative agent of meningococcal
disease, which kills an estimated 50,000 individuals worldwide
annually [1], Neisseria meningitidis is a frequent asymptomatic
coloniser of the human nasopharynx. Only a very small
proportion of infections proceed to a sustained bacteraemia and
thence to meningitis or septicaemia. Analysis of results from
multilocus enzyme electrophoresis (MLEE [2]) and multilocus
sequence typing (MLST [3]) have demonstrated the existence of
distinct phylogenetic groupings (termed lineages, or clonal
complexes), a small number of which are consistently more likely
to be isolated from patients than are others [4]. These are the so-
called hyper-virulent, or hyperinvasive, clonal complexes [3],
which are responsible for the large majority of meningococcal
disease worldwide.
The reasons for which disease occurs in some individuals and
not in others remain unclear, but both human and bacterial factors
are likely to be important in determining the outcome of infection.
The most important factors predisposing individuals to invasive
disease are the absence of bactericidal antibodies [5,6] and
dysfunction in the complement system [7]. The importance of
bacterial factors is exemplified by the absolute necessity of the
protective polysaccharide capsule for survival in the bloodstream
and subsequent disease. Several other bacterial structures have
been shown by laboratory assays to be important in pathogenesis,
such as type IV pili [8] and iron acquisition systems [9]. There are
no known virulence factors that are specific to hyperinvasive clonal
complexes. For example, many meningococci belonging to clonal
complexes that are not hyperinvasive are encapsulated and have
iron acquisition sytems; pili are required for colonisation of the
human nasopharynx whether or not this is followed by disease.
Furthermore, some established or potential virulence factors are
not universally present in meningococci isolated from invasive
disease. The pathogenicity of Neisseria meningitidis is multifactorial
and it is likely that many determinants important for the invasive
phenotype remain to be discovered.
Typical strategies for the discovery of novel virulence factors in
pathogens include the screening of banks of mutants, the mutation
of candidate genes chosen on the basis of homology to known
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DNA arrays to detect genes specific to pathogenic strains. Either as
an integral part of these techniques or as a subsequent validation
step, the effect of deletions of the identified gene will be evaluated
in animal or other laboratory models. However, for many human
diseases, and in particular in the case of meningococcal meningitis,
the difficulty of reproducing the human disease in animal models
has hampered the identification of novel virulence factors. An
alternative to such methods consists in molecular epidemiological
studies in the community, involving the analysis of isolates from
human disease and asymptomatic carriage. These studies are
founded on the expectation that the presence of a virulence gene is
correlated with a higher probability of being isolated from invasive
disease.
In a previous study [10] we compared the genomes of
meningococci belonging to clonal complexes designated as having
higher or lower invasive potential [11,12] and identified an 8-kb
genetic island which was significantly associated with meningo-
cocci causing invasive disease and which was named MDA for
Meningococcal Disease-Associated island. Subsequent analyses
suggest that the element corresponded to an integrated bacterio-
phage. Here, the presence of the MDA phage is surveyed in a
collection of 1288 meningococci, isolated from both disease and
carriage in south-east England between 1999 and 2001. The data
demonstrate that a large part of the invasiveness of strains
belonging to hyperinvasive clonal complexes is correlated with the
presence of the phage, and show an association with virulence in
young adults but not in children less than two years of age.
Methods
Meningococcal isolates
A collection of 1288 meningococcal isolates, collected in South
East England in 1999 and 2001, was surveyed for the presence of
the MDA phage. A total of 703 of these isolates were collected
before the introduction of the meningococcal conjugate C
polysaccharide vaccine and consisted of 500 meningococci isolated
from a carriage study performed in the Oxford area between
November and December 1999 [13] and 203 clinical isolates
collected from cases in south-east England between November
1998 and October 1999 and submitted to the England and Wales
National Reference Unit at Manchester (MRU). The remaining
585 isolates were collected after the vaccine introduction and
comprised 431 isolates from carriage, isolated in Oxford between
October 2001 and December 2001, and 154 meningococci
isolated from cases of invasive disease in south-eastern England
and submitted to the MRU between November 2000 and October
2001. Healthy carriers gave written consent for genetic character-
isation of meningococci isolated from their throats as described
[13]. The disease isolates were obtained from patients on
admission to hospital as part of the standard procedure for
diagnosis and treatment of meningococcal disease. Further
information concerning the isolates is provided in Table S1.
DNA techniques, PCR methods and oligonucleotide
primers
Meningococci were grown on Columbia blood agar plates
(Oxoid; containing 5% defibrinated horse blood) and chromosomal
DNA prepared with the Wizard Genomic DNA Purification kit
(Promega). The presence or absence of the MDA phage was
determined by long-range PCR amplification as described [10].
The possession of one or more copies of the MDA was detected by
the production of an amplification product of about 8 kbp. In order
to diminish problems caused by potential inhibitors of the PCR
present in the DNA preparations, when the initial result (using
about 0.5 mg of chromosomal DNA) was negative, the reaction was
repeated using a 1/10 dilution of the DNA preparation.
To confirm the amplification data a dot blot reaction was
performed. The DNA preparations (1 mg) were spotted onto nylon
membranes and reacted with probes prepared by PCR, corre-
sponding to approximately 700 bp fragments of ORFs 1, 6 and 9
of the MDA phage of strain Z2491 [10], and labelled with
32P.
The oligonucleotides used were as follows: for ORF1; GGCA-
TAACGCGCAAATGCAAATCA and CAGGTTCTAGCCC-
TTTGGGA (producing a fragment of length 757 bp), for
ORF6; GGGAAAAGTTAAGGAATCGTCCTGA and CA-
GACGGCAGATTTAAATCTTCTGC (producing a fragment
of 726 bp) and for ORF9; GGCATGGAGGCAACAGGCATC-
TATT and GGCTTACCCGCTTTTTTCAGATTAT (produc-
ing a fragment of 689 bp). Isolates giving discordant results for the
amplification and dot-blot experiments were retested.
Statistical analysis
The association of disease with both the presence of the MDA
phage and population structure as indexed by clonal complex was
measured as odds ratios using a logistic regression model. The
association of each of the larger clonal complexes with disease was
modelled using a categorical clonal complex variable for the larger
clonal complexes (those containing 15 or more isolates, being the
ST-8, 11, 22, 23, 35, 41/44, 53, 60, 103, 167, 198, 213, 269 and
1157 clonal complexes) and combining isolates not assigned to
clonal complexes and those from clonal complexes represented by
14 or fewer isolates in the dataset into a single category. An
unadjusted model was undertaken for the full dataset for each of
MDA and clonal complex. Multivariable models were used to
consider the independent effects of clonal complex and the presence
of the MDA prophage. The MDA prophage–disease association
was modelled with clonal complex included as a categorical
variable. Separate models were run for each major clonal complex
comparing isolates within that complex with the rest of the dataset
and adjusting for the presence of MDA. In the adjusted logistic
regression model isolates from clonal complexes with outcome
predicted completely by the model (ST-53 and ST-198 complexes,
present only in the carriage dataset) are dropped by the model.
These isolates are also excluded from the unadjusted model to allow
comparison between the two models. This results in a reduced
dataset (n=1186 for all ages, n=1105 when considering disease in
children only and n=790 for disease in those aged 11–30).
The distribution of MDA phage among disease-causing isolates
by age group was tested using a Chi square test. For the purposes
of this analysis, the isolates were divided into four groups of equal
size on the basis of patient age (less than two years old, two to 12,
13 to 28 and 29 or older). Two of these groups (the age brackets 0
to 1 years and 13 to 28 years) correspond to periods of peak
incidence of disease in young children and in young adulthood.
Results
Association of pathogenicity both with membership of
hyperinvasive clonal complexes and with possession of
the MDA phage
The MDA phage was present in 48% of the carried isolates at
both sampling times (240/500 isolates in 1999 and 205/431
isolates in 2001). It was present in 82.3% (167/203) of disease
isolates in 1999 and in 88.4% (136/154) of disease isolates in 2001.
The prevalence of the MDA phage in different clonal complexes
varied from 98% in the ST-11 complex, to none in the ST-53
clonal complex (Tables 1 and S2).
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sible respectively for 60 and 31% of disease). Non-groupable
organisms caused 3% of disease while they constituted 55% of the
carrier isolates. The phage was harboured by 78 percentage of
group B, 96% of group C and 44% of non-groupable isolates,
these figures differing by less than 7% between pre-and post-
vaccination samples.
Meningococcal isolates containing the MDA phage were more
likely to be isolated from invasive disease than from carriage in the
whole data set (OR=4.9; 95% CI 3.6–6.7) with no significant
difference in the pre- and post-vaccination samples (1999:
OR=3.9, CI 2.6–5.8; and 2001: OR=6.7, CI 3.9–11.4). Clonal
complex was also strongly associated with disease in the
unadjusted analysis (Table 2, unadjusted analysis), in agreement
with the studies which form the basis for the definition of
hyperinvasive complexes [3,4]. Consequently, after adjustment for
the existence of the different clonal complexes, the odds ratio for
association between MDA and disease was reduced (1.1; 95% CI
0.6–1.8) again showing no significant difference between the pre-
and post-vaccine samples (1999: OR=0.6, 95% CI 0.3–1.3; 2001:
OR 1.8, 95% CI 0.8–3.9).
Hence, in order to take into account the confounding effect of the
meningococcalpopulationstructure (thatis,todistinguishtheeffects
of clonal complex and of possession of the MDA phage on
virulence), we examined the effect of MDA on the disease-causing
potential of each of the 5 major hyperinvasive clonal complexes
separately, relative to the other complexes. Significantly,adjustment
for the presence of MDA diminished the apparent association of
disease with clonal complex by between 21% and 45% (Table 2),
implying that 21 to 45% of the invasive potential of these clonal
complexes is associated with the presence of the MDA.
The association of the MDA phage with disease in young
adults
The age distribution of the patients (Fig. 1A) was typical of
meningococcal disease, with a peak incidence in children under
the age of two years and a smaller peak of incidence in young
adults [6,14]. The age distribution of disease due to MDA-
Table 1. Distribution of the MDA Phage among Clonal Complexes.
Clonal complex Number of isolates Proportion with MDA phage (%)
Without MDA phage With MDA phage Total
ST-11 clonal complex 2 107 109 98.2
ST-32 clonal complex 1 29 30 96.7
ST-41/44 clonal complex 9 197 206 95.6
ST-269 clonal complex 6 112 118 94.9
ST-35 clonal complex 3 32 35 91.4
ST-1157 clonal complex 6 59 65 90.8
ST-8 clonal complex 2 13 15 86.7
ST-23 clonal complex 21 33 54 61.1
ST-103 clonal complex 15 6 21 28.6
ST-167 clonal complex 31 9 40 22.5
ST-60 clonal complex 76 10 86 11.6
ST-213 clonal complex 51 5 56 8.9
ST-22 clonal complex 108 10 118 8.5
ST-198 clonal complex 27 2 29 6.9
ST-53 clonal complex 73 0 73 0
Unassigned 86 95 181 52.5
doi:10.1371/journal.pone.0003885.t001
Table 2. Estimated Contribution of MDA to the Invasive Phenotype of Meningococci.




Carriage Disease Unadjusted Adjusted for MDA presence
ST-11 complex 11 98 31.6 [16.7–59.9] 19.6 [10.3–37.5] 0.38
ST-8 complex 3 12 10.8 [3.0–38.4] 8.5 [2.2–32.5] 0.21
ST-32 complex 12 18 4.0 [1.9–8.5] 2.4 [1.1–5.1] 0.40
ST-269 complex 58 60 3.0 [2.1–4.5] 1.8 [1.2–2.7] 0.40
ST-41/44 complex 108 98 2.9 [2.1–3.9] 1.6 [1.2–2.2] 0.45
doi:10.1371/journal.pone.0003885.t002
Bacteriophage in Meningococci
PLoS ONE | www.plosone.org 3 December 2008 | Volume 3 | Issue 12 | e3885Figure 1. Distribution of the integrated phage in disease isolates by age of patient. (A) Comparison of the age distribution of
meningococcal disease in the population studied. (B) Comparison of the age distribution of disease caused by MDA-positive (grey bars) and by MDA-
negative (white bars) meningococci. Numbers of cases in each of the two groups are separately normalised to unity. (C) Relative proportions of
disease in each of four age groups caused by MDA-positive or MDA-negative meningococci. The age groups were chosen in order to contain
approximately equal numbers of meningococcal isolates. Two of these (the age bracket 0 to 2 years and 13 to 28 years) correspond to the periods of
peak incidence of disease, respectively in infancy and in young adulthood.
doi:10.1371/journal.pone.0003885.g001
Bacteriophage in Meningococci
PLoS ONE | www.plosone.org 4 December 2008 | Volume 3 | Issue 12 | e3885containing meningococci, appeared different to that of disease
caused by MDA-negative bacteria (Fig. 1B), a difference that was
shown to be statistically significant (p=0.003, global Chi
2 for non-
random distribution; Fig. 1C). The results indicated a negative
association of the phage with children under two years of age, a
strong positive association of the phage with disease isolates in
young adults aged 13 to 28 years, the age group which forms the
main reservoir for N. meningitidis, and an intermediate distribution
in the other age groups (2 to 13 years, and over 29 years).
A separate analysis of the association of MDA with disease,
divided into 2 age groups with those with disease aged 0–10 years
and those aged 11–30 considered separately (Table 3), showed no
evidence for association of MDA with disease, independently of
clonal complex, in the 0–10 age group, but a substantial
association among adolescents and young adults (adjusted odds
ratio 3.9; 95% CI 1.1–13.6).
Discussion
The capsular polysaccharide remains the principal virulence
determinant for meningococci, with virtually all invasive disease
isolates elaborating a polysaccharide capsule corresponding to one
of the disease-associated serogroups (A, B, C, Y, W-135 and X). In
addition, iron acquisition systems and type IV pili are probably
also necessary for pathogenesis, but while possession of each of
these factors is necessary for invasive disease it is not sufficient. It is
likely that many other genetic factors, which remain largely
undefined, contribute to the capacity of a given meningococcus to
cause invasive disease.
Genomic comparisons using microarrays permit the detection
of candidate pathogenicity genes on the basis of their consistent
presence in invasive and their absence from less virulent
organisms. Typical methods of affirming the practical importance
of putative virulence factors require that the inactivation of a gene
have a measurable effect in an animal or ex vivo model of
pathogenesis. However, in the case of the meningococcus, an
exclusively human pathogen, such models are not representative of
the disease process and a factor promoting virulence in humans
may not be detected. The analysis of isolate collections from
carriage and disease in the community permits the confirmation of
potential virulence factors on the basis of a statistical association
with human disease, and circumvents the limitations of laboratory
models. We hypothesised firstly that a virulence gene would be
overrepresented in the hyperinvasive clonal complexes (by
definition responsible for the majority of disease) and then
secondly that, if the relation were causal rather than simply
clonal, there would exist within the hyperinvasive complexes an
association of the element with invasive disease.
We previously identified a candidate virulence factor, the MDA
prophage, by whole genome comparisons of well-characterised
isolates from an epidemic situation in 1993 in the Czech Republic
[10]. Here the association of the MDA phage with disease is
examined in an independent data set comprising 1288 isolates
from south-east England. A preliminary analysis of the results
confirmed the association of the element both with disease and
with certain clonal complexes, but did not permit the distinction
between the possibilities that the association of the prophage with
disease was due to the presence of a second virulence factor over-
represented in the hyperinvasive clonal complexes, or that the
prophage was one of the reasons for which the hyperinvasive
clonal complexes were more likely to cause disease.
This question was addressed by evaluating the effect of the
phage on the relative virulence of each clonal complex separately.
The frequent horizontal genetic exchange between strains of this
naturally competent species leads to genetic differences between
the meningococci comprising a given clonal complex [15] and to
differences in their pathogenic potential. This heterogeneity
provides the opportunity to analyse the association of a candidate
virulence gene with disease. In this way between 21 and 45% of
the disease-causing potential of the common hyperinvasive clonal
complexes could be attributed to the possession of the MDA
phage, or to factors accessory to the phage (Table 2), hence
supporting the hypothesis that the element acts, in concert with
other virulence factors, to increase the pathogenic potential of
meningococci.
As noted previously [10], the distribution of the MDA in the
collection of disease isolates was not uniform by age of patient.
While the prevalence of the MDA was approximately 88% in the
patients aged beween 2–12 or older than 28 years, it was over-
represented (93%) in the 13–28 year age band but under-
represented (75%) in those patients aged less than 2 years. These
findings suggest that the major part of the effect of the MDA on
increased invasive potential of meningococci is manifested in
young adults but not in infants. This is interesting in light of the
fact that young children are relatively unprotected by circulating
antibody, no longer being protected by maternally-derived
antibodies and not yet having acquired natural immunity by
carriage of non-virulent meningococci and other commensal
Neisseria [16,17]. It is possible that MDA promotes disease in
immunologically mature individuals, whereas its effect is not
apparent in young children who are susceptible to strains of lesser
virulence lacking MDA.
The means by which the bacteriophage could increase the
virulence of the host strains of meningococcus remain to be
determined, in contrast to some other cases (including invasive
group A streptococcal disease, cholera and haemolytic uraemic
syndrome caused by Escherichia coli) where disease symptoms are
largely determined by phage-carried toxin genes (reviewed in
[18,19]). In the case of the meningococcus, one possibility is that
genomic rearrangements induced by the element might lead to
changes in gene expression, hence disturbing the normal, non-
pathogenic relationship between bacterium and human. This
notion is in agreement with recent results from genome
comparisons between pathogenic Neisserial strains [20] and
between pathogens and carriage isolates [21].
In conclusion, comparative genomic analysis followed by
verification in a large-scale epidemiolgical survey shows that the
MDA phage is associated with invasiveness in meningococci in the
age group of young adults. The study highlights the power of
Table 3. Odds Ratio for Association between MDA and
Disease with and without Adjustment for Clonal Complex
Restricted by Age Group.
Age 0–10* Age 11–30*
Model (n=1005) (n=790)
Unadjusted OR 3.3 [2.2–4.8] 13.8 [6.0–31.9]
Adjusted{ OR 0.7 [0.4–1.3] 3.9 [1.1–13.6]
*Cases are divided into the age groups 0–10 years and 11–30 years. Carried
strains are carriage isolates from adolescents and young adults. Sample sizes
exclude isolates dropped from the models due to complete prediction as
indicated in the methods.
{Adjustment is for clonal complex modelled as a categorical variable. Clonal
complexes with less than 15 isolates and unassigned STs are grouped
together. Clonal complexes with 15 or more isolates are 8, 11, 22, 23, 32, 35,
41/44, 53, 60, 103, 167, 198, 213, 269, 1157.
doi:10.1371/journal.pone.0003885.t003
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collected in the community, particularly as an alternative to
classical techniques in the study of specifically human diseases,
where laboratory assays of pathogenicity correlates are not entirely
representative.
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